tumor	B:C0077503
necrosis	I:C0077503
factor	I:C0077503
and	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
cytokines	B:C0079189
may	O
regulate	B:C1327622
liver	B:C0023884
fat	B:C0015677
storage	O
under	O
homeostasis	B:C0019868
conditions	O
.	O

The	O
inflammation	B:C0021368
induced	O
by	O
obesogenic	B:C0012155
diets	I:C0012155
is	O
associated	O
with	O
deposition	O
of	O
fat	B:C0015677
in	O
the	O
liver	B:C0023884
.	O

On	O
the	O
other	O
hand	O
,	O
anti-inflammatory	B:C0087111
and	O
immunosuppressive	B:C0021079
therapies	I:C0021079
may	O
impact	O
in	O
body	B:C0242821
fat	B:C0015677
storage	O
and	O
in	O
liver	B:C0023884
lipid	B:C0023779
dynamics	O
.	O

It	O
is	O
important	O
to	O
study	O
specific	O
inflammatory	B:C0243042
mediators	I:C0243042
in	O
this	O
context	O
,	O
since	O
their	O
role	O
on	O
hepatic	B:C0151763
damage	I:C0151763
is	O
not	O
fully	O
clarified	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	B:C0220825
the	O
role	O
of	O
interleukin	B:C0383327
(	I:C0383327
IL	I:C0383327
)	I:C0383327
-	I:C0383327
18	I:C0383327
and	O
tumor	B:C0077503
necrosis	I:C0077503
factor	I:C0077503
(	I:C0077503
TNF	I:C0077503
)	I:C0077503
receptor	I:C0077503
in	O
liver	B:C0086565
dysfunction	I:C0086565
induced	O
by	O
diet	B:C0012155
.	O

Male	O
C57BL	B:C1521751
/	I:C1521751
6	I:C1521751
wild	B:C1520150
-	I:C1520150
type	I:C1520150
(	O
wild	B:C1520150
-	I:C1520150
type	I:C1520150
)	O
,	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
,	O
and	O
TNF	B:C1453724
receptor	I:C1453724
1	I:C1453724
knockout	B:C0206745
mice	I:C0206745
(	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
(	I:C0383327
-/-)	I:C0383327
and	O
TNFR1	B:C1453724
(-/-)	I:C1453724
)	O
were	O
divided	O
according	O
to	O
the	O
experimental	O
diets	B:C0012155
:	O
chow	B:C0012155
diet	I:C0012155
or	O
a	O
high	B:C0259835
-	I:C0259835
refined	I:C0259835
carbohydrate	I:C0259835
-	I:C0259835
containing	I:C0259835
diet	I:C0259835
.	O

Alanine	B:C0001899
aminotransferase	I:C0001899
was	O
quantified	O
by	O
colorimetric	B:C0009407
analysis	I:C0009407
.	O

Total	B:C0015677
fat	I:C0015677
content	O
in	O
the	O
liver	B:C0023884
was	O
determined	O
by	O
Folch	B:C0022885
methods	I:C0022885
.	O

Levels	O
of	O
tumor	B:C0077503
necrosis	I:C0077503
factor	I:C0077503
,	O
IL	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	B:C0021758
-	I:C0021758
4	I:C0021758
,	O
and	O
IL	B:C0214743
-	I:C0214743
13	I:C0214743
in	O
liver	B:C0023884
samples	O
were	O
measured	O
by	O
ELISA	B:C0014441
assay	I:C0014441
.	O

IL	B:C0383327
-	I:C0383327
18	I:C0383327
and	O
TNFR	B:C0077503
knockout	B:C0206745
mice	I:C0206745
fed	O
with	O
chow	B:C0012155
diet	I:C0012155
showed	O
higher	O
liver	B:C0023884
triglycerides	B:C0041004
deposition	O
than	O
WT	B:C1520150
mice	I:C1520150
fed	O
with	O
the	O
same	O
diet	B:C0012155
(	O
wild	B:C1520150
-	I:C1520150
type	I:C1520150
:	O
131.9	O
±	O
24.5	O
;	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
(-/-)	I:C0383327
:	O
239.4	O
±	O
38.12*	O
;	O
TNF	B:C0077503
(-/-)	I:C0077503
:	O
179.6	O
±	O
50.45	O
*	O
;	O
*P	O
<	O
0.01	O
)	O
.	O

Furthermore	O
,	O
these	O
animals	B:C0003062
also	O
showed	O
a	O
worse	O
liver	B:C0023884
histopathological	O
score	O
and	O
lower	O
levels	O
of	O
tumor	B:C0077503
necrosis	I:C0077503
factor	I:C0077503
,	O
IL	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	B:C0021758
-	I:C0021758
4	I:C0021758
,	O
and	O
IL	B:C0214743
-	I:C0214743
13	I:C0214743
in	O
the	O
liver	B:C0023884
.	O

Interestingly	O
,	O
treatment	O
with	O
a	O
high	B:C0259835
-	I:C0259835
carbohydrate	I:C0259835
diet	I:C0259835
did	O
not	O
exacerbate	O
liver	B:C0151763
damage	I:C0151763
in	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
(-/-)	I:C0383327
and	O
TNFR1	B:C1453724
(-/-)	I:C1453724
mice	B:C0025929
.	O

Our	O
data	O
suggest	O
that	O
IL	B:C0383327
-	I:C0383327
18	I:C0383327
and	O
tumor	B:C0077503
necrosis	I:C0077503
factor	I:C0077503
may	O
be	O
involved	O
on	O
hepatic	B:C0205054
homeostasis	B:C0019868
mainly	O
in	O
a	O
context	O
of	O
a	O
healthy	B:C0452415
diet	I:C0452415
.	O

